SecurityGRIF / Griffin Industrial Realty, Inc. (398231100)
President and CEOGamzon Michael
IndustryReal Estate
Institutional Owners39
Institutional Shares2,417,803 - 48.08%
Common Shares Outstanding5,028,608 shares (as of 2018-05-31)
Institutional Value$ 105,279,000 USD

Institutional Stock Ownership and Shareholders

GRIF / Griffin Industrial Realty, Inc.  Institutional Ownership

Griffin Industrial Realty, Inc. (NASDAQ:GRIF) has 39 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2,417,803 shares. Largest shareholders include Gamco Investors, Inc. Et Al, Gabelli Funds Llc, Teton Advisors, Inc., Dimensional Fund Advisors Lp, Franklin Resources Inc, BlackRock Inc., Vanguard Group Inc, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, and Bridgeway Capital Management Inc.
Griffin Industrial Realty, Inc. (NASDAQ:GRIF) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-08-14 13F-HR Tower Research Capital LLC (TRC) 73 0 -100.00 3 0 -100.00
2018-08-10 13F-HR Legal & General Group Plc 115 115 0.00 4 5 25.00
2018-08-14 13F-HR VANGUARD GROUP INC 71,855 109,791 52.80 2,697 4,829 79.05
2018-08-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 100 1,600 1,500.00 4 70 1,650.00
2018-09-18 13F-HR/A NORTHERN TRUST CORP 24,490 24,458 -0.13 920 1,076 16.96
2018-07-25 13F-HR BNP PARIBAS ARBITRAGE, SA 88 6 -93.18 3,303 264 -92.01
2018-08-14 13F-HR KINGS POINT CAPITAL MANAGEMENT 10,583 10,583 0.00 397 466 17.38
2018-08-14 13F-HR BRIDGEWAY CAPITAL MANAGEMENT INC 18,205 25,205 38.45 683 1,109 62.37
2018-08-14 13F-HR ROYAL BANK OF CANADA 1 3 200.00 0 0
2018-08-14 13F-HR BARCLAYS PLC 150 60 -60.00 5 2 -60.00
2018-08-14 13F-HR JP Morgan Chase & Co 150 169 12.67 6 7 16.67
2018-08-01 13F-HR WELLS FARGO & COMPANY/MN 3,845 2,309 -39.95 144 102 -29.17
2018-08-10 13F-HR GAMCO INVESTORS, INC. ET AL 837,113 810,114 -3.23 31,417 35,637 13.43
2017-02-10 13F-HR BlackRock Advisors LLC 1,073 1,073 0.00 34 34 0.00
2018-08-08 13F-HR AMERICAN INTERNATIONAL GROUP INC 444 543 22.30 17 24 41.18
2018-08-10 13F-HR CITIGROUP INC 520 166 -68.08 19 7 -63.16
2018-08-14 13F-HR UBS Group AG 0 104 0 5
2018-08-14 13F-HR FRANKLIN RESOURCES INC 122,000 122,000 0.00 4,579 5,367 17.21
2018-07-30 13F-HR TOWERVIEW LLC 48,827 0 -100.00 1,832 0 -100.00
2018-08-15 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 0 4,900 0 216
2018-08-13 13F-HR Ameritas Investment Partners, Inc. 55 55 0.00 2 2 0.00
2018-08-10 13F-HR GREAT WEST LIFE ASSURANCE CO /CAN/ 10 10 0.00 0 0
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 67,387 67,387 0.00 2,135 2,138 0.14
2018-08-14 13F-HR STATE STREET CORP 6,318 5,366 -15.07 238 235 -1.26
2018-07-27 13F-HR PIEDMONT INVESTMENT ADVISORS LLC 14 1
2018-07-27 13F-HR/A WHITTIER TRUST CO 100 100 0.00 4 4 0.00
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 0 6 0 0
2018-08-14 13F-HR GEODE CAPITAL MANAGEMENT, LLC 12,149 12,857 5.83 455 565 24.18
2018-08-10 13F-HR GABELLI FUNDS LLC 569,550 566,201 -0.59 21,375 24,907 16.52
2018-08-14 13F-HR MORGAN STANLEY 1,641 1,828 11.40 62 81 30.65
2018-05-11 13F-HR CITIGROUP INC 1,790 520 -70.95 65 19 -70.77
2018-08-14 13F-HR DEUTSCHE BANK AG\ 6,188 10,621 71.64 230 466 102.61
2018-08-14 13F-HR BANK OF AMERICA CORP /DE/ 809 940 16.19 30 41 36.67
2018-08-09 13F-HR Royce & Associates LLC 34,784 0 -100.00 1,305 0 -100.00
2018-08-09 13F-HR BlackRock Inc. 98,380 113,732 15.60 3,692 5,003 35.51
2017-02-10 13F-HR BlackRock Investment Management, LLC 705 705 0.00 22 22 0.00
2018-08-14 13F-HR UNITED CAPITAL FINANCIAL ADVISERS, LLC 5,925 261
2018-08-03 13F-HR SEI INVESTMENTS CO 6 101 1,583.33 0 4
2018-08-10 13F-HR Teton Advisors, Inc. 255,647 255,000 -0.25 9,594 11,217 16.92
2018-08-13 13F-HR Renaissance Technologies LLC 23,300 874
2017-02-10 13F-HR BlackRock Fund Advisors 23,440 27,376 16.79 743 869 16.96
2018-08-14 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 1,188 1,188 0.00 45 52 15.56
2018-08-10 13F-HR DIMENSIONAL FUND ADVISORS LP 205,911 211,372 2.65 7,728 9,298 20.32

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

CUSIP: 398231100